Analysis of clinical samples of SIRS/Sepsis patients also indicates that macrophages activate glycogen-PPP and UDPG-P2Y14 pathways to polarize an inflammatory phenotype, uncovering a potential strategy against clinical sepsis. This evidence concerns the gene P2RY14 and systemic inflammatory response syndrome.